Histologic transformation of EGFR mutant lung adenocarcinoma without exposure to EGFR inhibition.

Lung Cancer

Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, United States; The Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, United States. Electronic address:

Published: March 2017

Resistance to EGFR kinase inhibitors appears to be invariable in the treatment of non-small cell lung cancer. Several mechanisms have been described. Here, we report the first case of histologic transformation of EGFR mutant lung adenocarcinoma without prior exposure to EGFR inhibition.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5330183PMC
http://dx.doi.org/10.1016/j.lungcan.2017.01.005DOI Listing

Publication Analysis

Top Keywords

histologic transformation
8
transformation egfr
8
egfr mutant
8
mutant lung
8
lung adenocarcinoma
8
exposure egfr
8
egfr inhibition
8
egfr
5
adenocarcinoma exposure
4
inhibition resistance
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!